The Effects of Caffeine on Deep Inferior Epigastric Perforator (DIEP) Flap Perfusion

Withdrawn before enrolling · Not applicable

Conditions studied: Breast Reconstruction, Deep Inferior Epigastric Perforator, Microvascular Free Flap Transfer

In brief

Women that require breast reconstruction and meet eligibility will be enrolled in this study. The study is being completed to determine the effect of caffeine in deep inferior epigastric perforator (DIEP) flap perfusion using the Vioptix tissue oximeter monitor and to determine if caffeine in the acute postoperative period affects overall flap complication or loss (complete loss from anastomotic issue). The researchers hypothesize that a single 8 ounce cup of regular coffee will not affect free flap perfusion as indicated by the Vioptix, and that it will not affect overall free flap survival at thirty days.

Key facts

Study ID

NCT04249934

Run by

University of Michigan

People needed

0

Starts

2020-02-15

Expected to finish

2020-03-16

Last updated by the study team

2021-03-11

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• regular caffeine consumers undergoing unilateral or bilateral microsurgical breast reconstruction with DIEP flap(s) at the University of Michigan Health System

You may not qualify if…

• smokers
• hepatic or renal disease (comorbidities that affect caffeine metabolism)
• male

Where it is running

• University of Michigan — Ann Arbor, Michigan, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.